down arrow

Pharmaids Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE117D01018
  • NSEID:
  • BSEID: 524572
INR
66.70
-0.29 (-0.43%)
BSENSE

Apr 11, 12:50 PM

BSE+NSE Vol: 15.45 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

62.2068.00

52 Week

31.9087.46
Valuation
Technical
Day's Volume

CASH

15.45 k (139.14%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

5.22%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of % and Operating profit at 0% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -9.51
2

Risky - Negative EBITDA

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 236 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.17

stock-summary
Return on Equity

-11.87%

stock-summary
Price to Book

3.52

Revenue and Profits (1 Year):
Net Sales:
5 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-2 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
70.94%
0%
70.94%
1 Year
22.61%
0%
22.61%
2 Years
238.75%
0%
238.75%
3 Years
335.09%
0%
335.09%
4 Years
484.57%
0%
484.57%
5 Years
1382.22%
0%
1382.22%

Pharmaids Pharma for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
-9.51
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.19
Tax Ratio
24.20%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-29.64%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
3.52
EV to EBIT
-16.61
EV to EBITDA
-18.77
EV to Capital Employed
3.15
EV to Sales
16.41
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-18.94%
ROE (Latest)
-11.87%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Sadhanala Venkata Rao (4.4%)

Highest Public shareholder

Shankarappa Nagaraja Vinaya Babu (19.91%)

Individual Investors Holdings

36.42%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -10.11% vs 12.21% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 13.06% vs 17.16% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.71",
          "val2": "5.24",
          "chgp": "-10.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.88",
          "val2": "-2.56",
          "chgp": "-12.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.48",
          "val2": "0.33",
          "chgp": "45.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.01",
          "val2": "-0.07",
          "chgp": "85.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.93",
          "val2": "-2.22",
          "chgp": "13.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-61.15%",
          "val2": "-48.85%",
          "chgp": "-12.30%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 0.00% vs 0.00% in Sep 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -172.22% vs -160.87% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.97",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5.97",
          "val2": "-2.63",
          "chgp": "-127.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.15",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.90",
          "val2": "-1.80",
          "chgp": "-172.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-59.88%",
          "val2": "0.00%",
          "chgp": "-59.88%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 73,300.00% vs 0.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -131.53% vs -110.71% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14.68",
          "val2": "0.02",
          "chgp": "73,300.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.85",
          "val2": "-5.07",
          "chgp": "-74.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.08",
          "val2": "0.02",
          "chgp": "5,300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.16",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.83",
          "val2": "-2.95",
          "chgp": "-131.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-60.29%",
          "val2": "-25,350.00%",
          "chgp": "25,289.71%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 0.00% vs -100.00% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 34.52% vs -5,140.00% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.03",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.37",
          "val2": "-9.88",
          "chgp": "35.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.33",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-4.95",
          "val2": "-7.56",
          "chgp": "34.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-21,233.33%",
          "val2": "0.00%",
          "chgp": "-21,233.33%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
4.71
5.24
-10.11%
Operating Profit (PBDIT) excl Other Income
-2.88
-2.56
-12.50%
Interest
0.48
0.33
45.45%
Exceptional Items
-0.01
-0.07
85.71%
Consolidate Net Profit
-1.93
-2.22
13.06%
Operating Profit Margin (Excl OI)
-61.15%
-48.85%
-12.30%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -10.11% vs 12.21% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 13.06% vs 17.16% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
9.97
0.00
Operating Profit (PBDIT) excl Other Income
-5.97
-2.63
-127.00%
Interest
0.60
0.00
Exceptional Items
-0.15
0.00
Consolidate Net Profit
-4.90
-1.80
-172.22%
Operating Profit Margin (Excl OI)
-59.88%
0.00%
-59.88%
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

Growth in half year ended Sep 2024 is 0.00% vs 0.00% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -172.22% vs -160.87% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
14.68
0.02
73,300.00%
Operating Profit (PBDIT) excl Other Income
-8.85
-5.07
-74.56%
Interest
1.08
0.02
5,300.00%
Exceptional Items
-0.16
0.00
Consolidate Net Profit
-6.83
-2.95
-131.53%
Operating Profit Margin (Excl OI)
-60.29%
-25,350.00%
25,289.71%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 73,300.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -131.53% vs -110.71% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
0.03
0.00
Operating Profit (PBDIT) excl Other Income
-6.37
-9.88
35.53%
Interest
0.33
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-4.95
-7.56
34.52%
Operating Profit Margin (Excl OI)
-21,233.33%
0.00%
-21,233.33%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 0.00% vs -100.00% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 34.52% vs -5,140.00% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Pharmaids Pharmaceuticals Ltd stock-summary
stock-summary
Pharmaids Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Drugs
Pharmaids Pharmaceuticals Limited, incorporated in March, 1989 at Hyderabad, Telangana are the suppliers of Quality Grade range of speciality chemicals, skin care, hospital care and generic products in the areas of Orthopedic, Neuro and Gastro etc. The technical team uses quality proven chemical compounds and standard processing methods maintaining proper hygiene standards.
Company Coordinates stock-summary
Company Details
4-4-211/212/3 1st Floor, Inderbagh Sulthan Bazar Hyderabad Telangana : 500095
stock-summary
Tel: 91-40-66669809
stock-summary
http://www.pharmaids.com
stock-summary
mailpharmaids@yahoo.co.in
Registrar Details
Venture Capital & Corporate Investments Ltd , 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."